Skip to main content
Fig. 2 | Genome Medicine

Fig. 2

From: Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease

Fig. 2

Clinical characteristics for all study subjects. a–c Characteristics for control subjects (black), Crohn’s disease patients (CD, red), and ulcerative colitis patients (UC, blue) are plotted over time with unadjusted regression lines in black and 95 % confidence intervals in gray. For patients with CD and UC, calprotectin decreases (a), alpha diversity increases (b), and gut microbial dysbiosis decreases (c) over time, reflecting overall improvement following treatment. Additionally, calprotectin and microbial dysbiosis were significantly higher in our UC patients than in CD. (See also Additional file 2: Figures S1 and S2, Tables S3 and S4.)

Back to article page

Genome Medicine

ISSN: 1756-994X

Contact us